At 36 weeks, a reduction in fibrosis without worsening of MASH occurred in 8 of 61 patients (13%) in the placebo group, in 10 of 57 patients (18%) in the 28-mg efruxifermin group (difference from ...

Utilizing a filamentous fungus in the gut microbiome may provide a new strategy for treating metabolic dysfunction-associated steatohepatitis (MASH). Researchers have developed an innovative ...

Zony Mash Beer Project (3940 Thalia St.) has announced it is closing, with its final day scheduled for June 1. The brewery and its taproom remain open until then, serving Wednesday through Sunday ...

After 24 years, Mash House Brewing Company in Fayetteville has closed. The brewery and restaurant, known for its handcrafted beers and meals, announced its closure on April 10. Mash House's ...

Potter has just learned that James Cardinal Reardon, the “honcho padre himself,” is going to be visiting the 4077th M*A*S*H on Sunday in time to hear Mulcahy’s weekly sermon. At this ...

Nwd1 gene deletion triggers MASH-like pathology in mice Study highlights the role of the Nwd1 gene in liver disease, paving the way for new therapies and better liver health Date: March 11, 2025 ...

Resmetirom significantly reduced liver stiffness in patients with compensated MASH cirrhosis, with a 6.7 kPa decrease over 2 years. The reduction in liver stiffness may lower the risk of liver ...

MASH is a leading cause of chronic liver disease and a significant driver of liver cirrhosis and hepatic cellular carcinoma, impacting approximately 5% of adults worldwide. Despite its widespread ...

Metabolic dysfunction-associated steatohepatitis (MASH) is often referred to as a “silent disease,” as it typically shows no signs of symptoms in early stages. But it can come with certain ...

Walmart is giving its logo the first facelift in nearly two decades, rolling out a new identity that is a subtle nod to its past. The 61-year-old company unveiled Monday a refresh of its brand ...

What Are Clinical Trials for MASH? Clinical trials for MASH are research studies that evaluate potential new treatments for a form of liver disease called metabolic dysfunction-associated ...